MediTox s.r.o.

Main activities

Non clinical R & D related to ophthalmic diseases (chronic glaucoma), contact dermatitis, osteoarthritis, non-clinical development of vaccines (influenza, adenovirus, etc.), inflammatory bowel diseases, non-alcoholic steatohepatitis (NASH)

Comprehensive non-clinical and toxicological program for assessment of human/veterinary drugs, vaccines, biological products, medical devices and food/feed additives (EMA/ICH/VICH/FDA/ISO), chemical substances and preparations (ECHA)

Models of selected human diseases - chronic glaucoma, contact dermatitis, osteoarthritis, non-clinical development of vaccines, inflammatory bowel diseases, non-alcoholic steatohepatitis,…

Accredited breeding facility (CZ 02396)

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.

MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.

The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with flexibility and competitive pricing.

We will attend following events:

CEBioForum 2022, May 25 – 26, 2022, Warsaw, Poland

CEBioForum 2022

BIO International Convention, June 13 – 16, 2022, San Diego, USA

BIO International Convention

Nordic Life Sciences 2022, September 28 – 29, 2022 Malmő, Sweden

Nordic Life Sciences 2022

BIO-EUROPE autumn, 2022, October 24 – 26, 2022, Leipzig, Germany

BIO-EUROPE autumn, 2022

BioFIT 2022, November 29-30, 2022 Strasbourg, France

BioFIT 2022

MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.